$VRX News
Last published 2w ago
- 2w agoVRXBausch Health Third-Quarter 2026 Earnings Conference Call - VALEANT PHARMACEUTICALS INTERNATIONALEarnings Call TranscriptsGreetings, and welcome to the Bosch Health Third Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyo
- 9y agoADPHHCVRXCP+10Pershing Square’s Nominees for ADP’s Transformation to Participate in a Fireside ChatBusiness WireNEW YORK--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”) today announced that Pershing Square CEO Bill Ackman, Veronica Hagen and Paul Unruh (“The Nominees for ADP’s Transformation”) will participate in a fireside chat hosted and moderated by Sanford C. Bernstein & Co. (“Bernstein”) Senior Analyst Lisa Ellis in Chicago on October 19, 2017, at 1:00 PM EDT / 12:00 PM C ...
- 10y agoVRXValeant Pharmaceuticals International (VRX) Q3 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoVRXValeant Pharmaceuticals International (VRX) Joseph C. Papa on Q2 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoVRXValeant Pharmaceuticals International's (VRX) CEO Joseph Papa on Q1 2016 Results - Earnings Call TranscriptEarnings Call Transcripts
- 10y agoVRXValeant Pharmaceuticals' (VRX) CEO Michael Pearson on Q4 2015 Results - Earnings Call TranscriptEarnings Call Transcripts
- 12y agoAGNVRXAllergan Issues Statement Regarding Recent Valeant CorrespondenceBusiness WireIRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued a statement regarding recent correspondence between Allergan and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (“Valeant”) that was published by Valeant:
- 12y agoVRXAGNPershing Square, Valeant and Allergan Settle Pending Litigation Before the Delaware Court of ChanceryBusiness WireNEW YORK & LAVAL, Quebec--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”) and Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) (“Valeant”) announced an agreement with Allergan, Inc. (NYSE:AGN) (“Allergan”) to settle pending litigation before the Delaware Court of Chancery.
- 12y agoAGNVRXAllergan to Hold Special Meeting of Stockholders on Originally Scheduled Date of December 18 without RestrictionBusiness WireIRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that it has reached an agreement with Pershing Square Capital Management, L.P. (“Pershing Square”) and Valeant Pharmaceuticals (NYSE: VRX) (“Valeant”) under which Allergan will hold the Special Meeting of Stockholders (the “Special Meeting”) on the originally scheduled date of December 18, 201 ...
- 12y agoAGNVRXPershing Square Submits Additional Special Meeting RequestsBusiness WireNEW YORK--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”), the largest shareholder of Allergan, Inc. (NYSE:AGN) (“Allergan”), announced that on Friday it submitted to Allergan additional special meeting requests from shareholders owning approximately 0.6% of Allergan’s shares. With these requests, Pershing Square has delivered requests from 51 institutions representin ...
- 12y agoAGNVRXPershing Square Submits Additional Special Meeting Requests Representing 35% of Allergan SharesBusiness WireNEW YORK--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”), the largest shareholder of Allergan, Inc. (NYSE:AGN) (“Allergan”), announced today that it has submitted additional special meeting requests from shareholders owning 1.29% of Allergan’s shares, bringing the total to 35.1%. Not including Pershing Square, shareholders owning over 25% of Allergan’s shares have no ...
- 12y agoAGNVRXAllergan to Request California Federal Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading LawsBusiness WireIRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) announced today that it has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction against Valeant Pharmaceuticals (NYSE: VRX) (“Valeant”), Pershing Square Capital Management, L.P. (“Pershing Square”), ...
- 12y agoAGNVRXPershing Square Submits Requisite Requests from Allergan Shareholders to Call Special MeetingBusiness WireNEW YORK--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”), the largest shareholder of Allergan, Inc. (NYSE:AGN) (“Allergan”), announced today that it submitted the required documentation to compel Allergan to call a special meeting of Allergan shareholders. The written requests, from shareholders owning 31% of Allergan’s shares, exceed the requirements under Allergan’ ...
- 12y agoAGNVRXPershing Square Files Lawsuit in Delaware Court of Chancery Seeking Confirmation that Allergan’s Rights Plan Is Not Triggered by Efforts to Call a Special MeetingBusiness WireNEW YORK--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”) announced today that an affiliate has filed a lawsuit in the Delaware Court of Chancery seeking a declaratory judgment confirming that its actions in connection with the solicitation and receipt of revocable proxies to call a special meeting of shareholders of Allergan, Inc. (“Allergan”) (NYSE:AGN) will not tri ...
- 14y agoMRXVRXFaruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)Business WireNEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Medicis Pharmaceutical Corp. (“Medicis” or the “Company”) (NYSE: MRX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Valeant Pharmaceuticals International Inc. (NYSE: VRX) in ...
- 14y agoMRXVRXRobbins Umeda LLP Announces an Investigation of Medicis Pharmaceutical Corp.Business WireSAN DIEGO--(BUSINESS WIRE)--Shareholder rights firm Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by members of the board of directors of Medicis Pharmaceutical Corp. (NYSE: MRX) in connection with their efforts to sell the company to Valeant Pharmaceuticals International, Inc. (NYSE: VRX). Concerned shareholders who would ...
- 14y agoMRXVRXFaruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of Medicis Pharmaceutical Corp. (MRX)Business WireNEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Medicis Pharmaceutical Corp. (“Medicis” or the “Company”) (NYSE: MRX) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Valeant Pharmaceuticals International Inc. (NYSE: VRX) in ...
- 14y agoMRXVRXRigrodsky & Long, P.A. Announces Investigation Of Medicis Pharmaceutical Corporation BuyoutBusiness WireWILMINGTON, Del.--(BUSINESS WIRE)--Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Medicis Pharmaceutical Corporation (“Medicis” or the “Company”) (NYSE: MRX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Valeant Pharmaceuticals Interna ...